<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35430704</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1179-2000</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Molecular diagnosis &amp; therapy</Title>
          <ISOAbbreviation>Mol Diagn Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>EasyNAT MP Assay: A Simple, Rapid, and Low-Cost Method to Detect Mycoplasma pneumoniae Using Cross-Priming Amplification Technology.</ArticleTitle>
        <Pagination>
          <StartPage>345</StartPage>
          <EndPage>352</EndPage>
          <MedlinePgn>345-352</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40291-022-00582-6</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mycoplasma pneumoniae (MP) is the most common pathogen of atypical pneumonia and the main cause of community-acquired pneumonia (CAP) in infants and older adults. This study aimed at investigating a method based on the cross-priming amplification (CPA) technique for the rapid detection of MP in clinical specimens collected from patients with CAP.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The sensitivity and specificity of the EasyNAT MP assay were determined. Oropharyngeal swab specimens were collected from 162 in-patients of Hangzhou First People's Hospitals from January 2018 to December 2020. The patients were aged between 1 and 15 years with symptoms, signs, and chest radiographs consistent with CAP. This study evaluated the presence of MP in the clinical specimens using the EasyNAT method and the conventional fluorescence quantitative PCR technique.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The limit of detection using the EasyNAT MP assay was 500 copies/mL, while the test results of the other 13 common pathogens causing CAP or colonizing in the upper respiratory tract showed no cross-reactivity. Of 162 specimens, EasyNAT MP gave a positive indication in 82 specimens. Compared with conventional fluorescence quantitative PCR, the positive coincidence rate and the negative coincidence rate of EasyNAT MP was found to be 100.00% and 97.56%, respectively. Of the 82 specimens, two specimens were determined to be negative by the conventional fluorescence quantitative PCR, but were positive for EasyNAT MP. The two samples were re-extracted and confirmed to be positive by conventional fluorescence quantitative PCR.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">EasyNAT MP is suitable as an initial test for MP diagnosis due to its simplicity, low turnaround time, and high sensitivity and specificity.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Guang</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310012, Zhejiang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Junwei</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Ustar Biotechnologies (Hangzhou) Ltd., Hangzhou, 310053, Zhejiang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Hanlu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310000, Zhejiang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cen</LastName>
            <ForeName>Ke</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Yanqiong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Ustar Biotechnologies (Hangzhou) Ltd., Hangzhou, 310053, Zhejiang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>You</LastName>
            <ForeName>Qimin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Ustar Biotechnologies (Hangzhou) Ltd., Hangzhou, 310053, Zhejiang, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Shenghai</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-9923-1014</Identifier>
            <AffiliationInfo>
              <Affiliation>The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310000, Zhejiang, People's Republic of China. wu_shai@163.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Laboratory, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, People's Republic of China. wu_shai@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Mol Diagn Ther</MedlineTA>
        <NlmUniqueID>101264260</NlmUniqueID>
        <ISSNLinking>1177-1062</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017714" MajorTopicYN="Y">Community-Acquired Infections</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045142" MajorTopicYN="N">Cross-Priming</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009177" MajorTopicYN="N">Mycoplasma pneumoniae</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011019" MajorTopicYN="Y">Pneumonia, Mycoplasma</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013672" MajorTopicYN="N">Technology</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>Yu Junwei, Zhou Yanqiong, and You Qimin are employed by Ustar Biotechnologies (Hangzhou) Ltd.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>21</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35430704</ArticleId>
        <ArticleId IdType="pmc">PMC9098574</ArticleId>
        <ArticleId IdType="doi">10.1007/s40291-022-00582-6</ArticleId>
        <ArticleId IdType="pii">10.1007/s40291-022-00582-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Gao LW, Yin J, Hu YH, Liu XY, Feng XL, He JX, Liu J, Guo Y, Xu BP, Shen KL. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016. Epidemiol Infect. 2019;147:e192. doi: 10.1017/S0950268819000839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268819000839</ArticleId>
            <ArticleId IdType="pmc">PMC6518602</ArticleId>
            <ArticleId IdType="pubmed">31364532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beeton ML, Zhang XS, Uldum SA, Bébéar C, Dumke R, Gullsby K, Ieven M, Loens K, Nir-Paz R, Pereyre S, Spiller OB, Chalker VJ. Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016. Euro Surveill. 2020;25(2):pii=1900112.</Citation>
        </Reference>
        <Reference>
          <Citation>Kong DC, Wu HY, Zheng YX, Pan H, Jiang CY, Zhang X, Chen J, Wu F. Etiologic and epidemiologic features of acute respiratory infections in adults from Shanghai, during 2015–2017. Zhonghua liu xing bing xue za zhi Zhonghua liuxingbingxue zazhi. 2019;40(8):904–910.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31484252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee E, Kim CH, Lee YJ, Kim HB, Kim BS, Kim HY, Kim Y, Kim S, Park C, Seo JH, et al.  Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis. 2020;20(1):132. doi: 10.1186/s12879-020-4810-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-020-4810-9</ArticleId>
            <ArticleId IdType="pmc">PMC7017508</ArticleId>
            <ArticleId IdType="pubmed">32050912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dierig A, Hirsch HH, Decker ML, Bielicki JA, Heininger U, Ritz N. Mycoplasma pneumoniae detection in children with respiratory tract infections and influence on management—a retrospective cohort study in Switzerland. Acta Paediatr. 2020;109(2):375–380. doi: 10.1111/apa.14891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apa.14891</ArticleId>
            <ArticleId IdType="pmc">PMC7159768</ArticleId>
            <ArticleId IdType="pubmed">31168877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zao I, Ribeiro F, Rocha V, Neto P, Matias C, Jesus G. Mycoplasma pneumoniae-associated Mucositis: a recently described entity. Eur J Case Rep Intern Med. 2018;5(11):000977.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6346809</ArticleId>
            <ArticleId IdType="pubmed">30755992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amode R, Ingen-Housz-Oro S, Ortonne N, Bounfour T, Pereyre S, Schlemmer F, Bequignon E, Royer G, Wolkenstein P, Chosidow O. Clinical and histologic features of Mycoplasma pneumoniae-related erythema multiforme: a single-center series of 33 cases compared with 100 cases induced by other causes. J Am Acad Dermatol. 2018;79(1):110–117. doi: 10.1016/j.jaad.2018.03.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaad.2018.03.013</ArticleId>
            <ArticleId IdType="pubmed">29559400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watkins LKF, Olson D, Diaz MH, Lin X, Demirjian A, Benitez AJ, Winchell JM, Robinson CC, Bol KA, Glodé MP, et al.  Epidemiology and molecular characteristics of mycoplasma pneumoniae during an outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome. Pediatric Infect Dis J. 2017;36(6):564–571. doi: 10.1097/INF.0000000000001476.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000001476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Groot RCA, Meyer Sauteur PM, Unger WWJ, van Rossum AMC. Things that could be Mycoplasma pneumoniae. J Infect. 2017;74(Suppl 1):S95–s100. doi: 10.1016/S0163-4453(17)30198-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0163-4453(17)30198-6</ArticleId>
            <ArticleId IdType="pubmed">28646969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar S, Roy RD, Sethi GR, Saigal SR. Mycoplasma pneumoniae infection and asthma in children. Trop Doct. 2019;49(2):117–119. doi: 10.1177/0049475518816591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0049475518816591</ArticleId>
            <ArticleId IdType="pubmed">30537911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dien Bard J, Hong T, Prichard M, Brooks E, Dallas S, Duffy L, Mixon E, Fowler KB, Atkinson TP, Parrott GL, et al.  A Compendium for Mycoplasma pneumoniae. J Clin Microbiol. 2016;7:513.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang Z, Du J, Liu T, Wang F, Jia J, Dong L, Zhao L, Xue Y, Jiang G, Yu X, et al.  EasyNAT MTC assay: a simple, rapid, and low-cost cross-priming amplification method for the detection of mycobacterium tuberculosis suitable for point-of-care testing. Emerg Microbes Infect. 2021;10(1):1530–1535. doi: 10.1080/22221751.2021.1959271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/22221751.2021.1959271</ArticleId>
            <ArticleId IdType="pmc">PMC8330774</ArticleId>
            <ArticleId IdType="pubmed">34288833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang R, Li X, Hu L, You Q, Li J, Wu J, Xu P, Zhong H, Luo Y, Mei J, et al.  Cross-priming amplification for rapid detection of Mycobacterium tuberculosis in sputum specimens. J Clin Microbiol. 2009;47(3):845–847. doi: 10.1128/JCM.01528-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01528-08</ArticleId>
            <ArticleId IdType="pmc">PMC2650920</ArticleId>
            <ArticleId IdType="pubmed">19116359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guan Y, Wang K, Zeng Y, Ye Y, Chen L, Huang T. Development of a direct and rapid detection method for viable but non-culturable state of Pediococcus acidilactici. Front Microbiol. 2021;12:687691. doi: 10.3389/fmicb.2021.687691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2021.687691</ArticleId>
            <ArticleId IdType="pmc">PMC8283312</ArticleId>
            <ArticleId IdType="pubmed">34276618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Gao S, Zhang S, He X, Liu J, Liu A, Li Y, Liu G, Luo J, Guan G, et al.  Rapid detection of Babesia motasi responsible for human babesiosis by cross-priming amplification combined with a vertical flow. Parasit Vectors. 2020;13(1):377. doi: 10.1186/s13071-020-04246-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13071-020-04246-4</ArticleId>
            <ArticleId IdType="pmc">PMC7391542</ArticleId>
            <ArticleId IdType="pubmed">32727550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):E63. doi: 10.1093/nar/28.12.e63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/28.12.e63</ArticleId>
            <ArticleId IdType="pmc">PMC102748</ArticleId>
            <ArticleId IdType="pubmed">10871386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arfaatabar M, Noori Goodarzi N, Afshar D, Memariani H, Azimi  G, et al.  Rapid detection of Mycoplasma pneumoniae by loop-mediated isothermal amplification (LAMP) in clinical respiratory specimens. Iran J Public Health. 2019;48(5):917–924.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6717426</ArticleId>
            <ArticleId IdType="pubmed">31523649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017;30(3):747–809. doi: 10.1128/CMR.00114-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00114-16</ArticleId>
            <ArticleId IdType="pmc">PMC5475226</ArticleId>
            <ArticleId IdType="pubmed">28539503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu G, Hu L, Zhong H, Wang H, Yusa S, Weiss TC, Romaniuk PJ, Pickerill S, You Q. Cross priming amplification: mechanism and optimization for isothermal DNA amplification. Sci Rep. 2012;2:246. doi: 10.1038/srep00246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep00246</ArticleId>
            <ArticleId IdType="pmc">PMC3271364</ArticleId>
            <ArticleId IdType="pubmed">22355758</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
